Yuyu Pharma, Inc.

KOSE:A000220 주식 보고서

시가총액: ₩68.0b

Yuyu Pharma 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Robert Yu

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기4.6yrs
CEO 소유권26.6%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Unpleasant Surprises Could Be In Store For Yuyu Pharma, Inc.'s (KRX:000220) Shares

Nov 13
Unpleasant Surprises Could Be In Store For Yuyu Pharma, Inc.'s (KRX:000220) Shares

Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance

Aug 24
Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance

Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now

Aug 07
Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now

Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden

Apr 02
Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden

Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?

Mar 08
Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?

The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More

Feb 10
The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More

We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide

Jan 07
We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide

Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly

Dec 20
Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly

Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?

Dec 03
Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?

CEO

Robert Yu

4.6yrs

테뉴어

Mr. Wonsang Yu, also known as Robert, has been President and Chief Executive Officer of Yuyu Pharma, Inc. since April 6, 2020 and served as its Vice President. Prior to joining Yuyu Pharma in 2008, Mr. Yu...